Bulletin
Investor Alert

Radius Health Inc.

NAS: RDUS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 4:00 p.m.

/zigman2/quotes/200442286/composite

$

6.25

Change

0.00 0.00%

Volume

Volume 11,726

Quotes are delayed by 20 min

/zigman2/quotes/200442286/composite

Previous close

$ 5.84

$ 6.25

Change

+0.41 +7.02%

Day low

Day high

$5.53

$6.25

Open

52 week low

52 week high

$4.97

$23.00

Open

Company Description

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also inclu...

Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA.

Valuation

Price to Sales Ratio

1.42

Enterprise Value to EBITDA

-9.51

Enterprise Value to Sales

2.33

Efficiency

Total Asset Turnover

1.23

Liquidity

Current Ratio

1.83

Quick Ratio

1.71

Cash Ratio

1.18

Profitability

Gross Margin

91.52

Operating Margin

-23.62

Pretax Margin

-30.51

Net Margin

-30.51

Return on Assets

-37.62

Return on Total Capital

-52.16

Capital Structure

Total Debt to Total Assets

187.10

Officers and Executives

Name Age Officer Since Title
Mr. George Kelly Martin 62 2020 President, Chief Executive Officer & Director
Mr. Mike Conley 59 2022 CFO, Treasurer, Chief Accounting Officer & VP
Ms. Allison Ross - 2020 Head-Information Technology
Dr. Bruce Mitlak - 2020 Chief Medical Officer
Mr. Peter A. Schwartzman - 2020 Vice President-Capital, Strategy & Transactions

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/15/2022 Mark Conley
VP, Chief Financial Officer
50,000   Award at $0 per share. 0
02/21/2022 George Kelly Martin
CEO and President; Director
75,000   Award at $0 per share. 0
02/21/2022 George Kelly Martin
CEO and President; Director
960,000   Award at $0 per share. 0
01/14/2022 Chhaya Shah
Chief Business Officer
65,000   Award at $0 per share. 0
01/14/2022 Steven Helwig
Principal Financial Officer
15,000   Award at $0 per share. 0
01/14/2022 Jean-Pierre Garnier
Director
5,500   Award at $0 per share. 0
01/14/2022 Catherine J. Friedman
Director
5,500   Award at $0 per share. 0
01/14/2022 Danielle Holtschlag
Vice President, Sales
25,000   Award at $0 per share. 0
01/14/2022 Willard H. Dere
Director
5,500   Award at $0 per share. 0
01/14/2022 Owen Patrick Hughes
Director
5,500   Award at $0 per share. 0
01/14/2022 Sean E. Murphy
Director
5,500   Award at $0 per share. 0
01/14/2022 Andrew C. von Eschenbach
Director
5,500   Award at $0 per share. 0
01/14/2022 A. Machelle Sanders
Director
5,500   Award at $0 per share. 0
01/06/2022 Bellevue Asset Management AG
300,000   Acquisition at $6.31 per share. 1,893,000
01/05/2022 Bellevue Asset Management AG
250,000   Acquisition at $6.3 per share. 1,575,000
12/16/2021 Rubric Capital Management LP
146,685   Acquisition at $7.07 per share. 1,037,062
12/15/2021 Rubric Capital Management LP
180,744   Acquisition at $6.77 per share. 1,223,636
12/14/2021 Rubric Capital Management LP
94,103   Acquisition at $6.81 per share. 640,841
12/13/2021 Rubric Capital Management LP
187,391   Acquisition at $7.08 per share. 1,326,728
12/10/2021 Rubric Capital Management LP
768,171   Acquisition at $7.18 per share. 5,515,467
/news/latest/company/us/rdus

MarketWatch News on RDUS

  1. Radius Health started at underperform with $16 stock price target at BofA Securities

    11:39 a.m. Dec. 3, 2021

    - Tomi Kilgore

  2. Radius Health started at hold with $20 stock price target at Stifel Nicolaus

    7:17 a.m. April 24, 2020

    - Tomi Kilgore

  3. How to invest in biotech stocks like a Nobel Prize winner

    11:47 a.m. Oct. 24, 2019

    - Michael Brush

  4. Nutrisystem: Starved for Attention

    1:20 p.m. Aug. 21, 2018

    - Barron's Online

  5. Activist Elliott Management Weighs Athenahealth

    10:58 p.m. May 26, 2017

    - Barron's Online

  6. Jana Partners Sees Sparkle in Tiffany

    2:13 a.m. March 4, 2017

    - Barron's Online

  7. Elliott Associates Sees Potential in Advisory Board Co. Sale

    1:35 a.m. Jan. 21, 2017

    - Barron's Online

  8. Charting the S&P 500’s approach of the 2016 peak

    11:26 a.m. July 8, 2016

    - Michael Ashbaugh

  9. Barrons.com Stock Picks Just Behind Index in ’15

    5:57 p.m. Feb. 9, 2016

    - Barron's Online

  10. Biotech Stocks Now Seeing Bullish Signs in the Charts

    8:59 a.m. Nov. 13, 2015

    - Barron's Online

  11. Radius Health started at overweight with $88 stock price target at J.P. Morgan

    7:53 a.m. Oct. 2, 2015

    - Tomi Kilgore

  12. Amgen vs Radius: Who Will Dominate Bone Density Market?

    3:23 p.m. Aug. 17, 2015

    - Barrons Blogs

  13. Barrons.com Stock Picks Handily Beat the Market

    10:36 a.m. July 20, 2015

    - Barron's Online

  14. Barrons.com Stock Picks Handily Beat the Market

    4:37 p.m. July 16, 2015

    - Barron's Online

  15. 5 stocks to watch

    1:35 p.m. July 9, 2015

    - The Trading Deck

  16. 6 stocks to watch

    3:36 p.m. June 24, 2015

    - The Trading Deck

  17. Radius Health downgraded to hold from buy at Maxim

    7:49 a.m. June 22, 2015

    - Tomi Kilgore

  18. Radius Health stock price target raised to $60 from $50 at Maxim Group

    7:50 a.m. June 22, 2015

    - Tomi Kilgore

  19. Radius Health Looks Fully Valued

    4:27 p.m. April 27, 2016

    - Barron's Online

  20. Loading more headlines...
/news/nonmarketwatch/company/us/rdus

Other News on RDUS

  1. Radius Health (RDUS) Q1 2022 Earnings Call Transcript

    1:30 p.m. May 6, 2022

    - Motley Fool

  2. 10-Q: RADIUS HEALTH, INC.

    12:22 p.m. May 5, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. Radius Health Q1 2022 Earnings Preview

    12:16 p.m. May 4, 2022

    - Seeking Alpha

  4. Notable earnings before Thursday's open

    11:07 a.m. May 4, 2022

    - Seeking Alpha

  5. Radius Health files sNDA for osteoporosis drug Tymlos in men

    8:33 a.m. March 1, 2022

    - Seeking Alpha

  6. Radius (RDUS) Q4 Earnings & Revenues Surpass Estimates

    11:03 a.m. Feb. 25, 2022

    - Zacks.com

  7. Radius Health (RDUS) Q4 2021 Earnings Call Transcript

    6:30 p.m. Feb. 24, 2022

    - Motley Fool

  8. Reevaluating Radius Health

    3:20 p.m. Feb. 24, 2022

    - Seeking Alpha

  9. Loading more headlines...

At a Glance

Radius Health, Inc.

22 Boston Wharf Road

7th floor

Boston, Massachusetts 02210

Phone

1 6175514000

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

$229.97M

Net Income

$-70.18M

Employees

293.00

/news/pressrelease/company/us/rdus

Press Releases on RDUS

  1. Radius Health, Inc. First Quarter 2022 Results

    7:55 a.m. May 5, 2022

    - GlobeNewswire

  2. Radius Provides Agenda for Today's R&D Webcast

    8:00 a.m. April 5, 2022

    - GlobeNewswire

  3. Radius Health Announces Leadership Appointments

    8:30 a.m. March 16, 2022

    - GlobeNewswire

  4. Radius Health Provides Business Update on Bone Health

    9:30 a.m. March 8, 2022

    - GlobeNewswire

  5. Radius to Host Neuroscience R&D Webcast April 5, 2022

    5:05 p.m. March 3, 2022

    - GlobeNewswire

  6. Radius Health Files sNDA for TYMLOS(R) in Men with Osteoporosis

    9:00 a.m. March 1, 2022

    - GlobeNewswire

  7. Radius Health, Inc. Fourth Quarter & Full Year 2021 Results

    8:31 a.m. Feb. 24, 2022

    - GlobeNewswire

  8. Radius Health Completes Business Adjustment

    10:00 a.m. Jan. 13, 2022

    - GlobeNewswire

  9. Radius Announces Update on TYMLOS(R) (abaloparatide) Label

    9:30 a.m. Dec. 23, 2021

    - GlobeNewswire

  10. Loading more headlines...
Link to MarketWatch's Slice.